Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04535362 · ClinicalTrials.gov registry record · Early Phase 1
Nicotine's Potential Abuse With Menthol
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT04535362 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 16 participants.
The verdict
NCT04535362, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To examine if switching from menthol to non-menthol cigarettes will change the dose-effect curves for positive subjective effects and alleviation of smoking urges as a function of nicotine delivery rate in smokers.
Interventions
- DRUG Nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2023-06-29 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04535362
The ClinicalTrials.gov registry entry for NCT04535362 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine is the first listed.
NCT04535362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04535362 about?
NCT04535362 is a clinical study titled "Nicotine's Potential Abuse With Menthol". To examine if switching from menthol to non-menthol cigarettes will change the dose-effect curves for positive subjective effects and alleviation of smoking urges as a function of nicotine delivery rate in smokers.
What is the current status of trial NCT04535362?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2021-06-28. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT04535362?
The interventions under investigation include: Nicotine (DRUG).
Who is sponsoring clinical trial NCT04535362?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.